We are live on ! Find out more
HSA

Hussman Strategic Advisors Portfolio holdings

AUM $463M
1-Year Est. Return 16%
This Fund
S&P 500
This Quarter Est. Return
-0.77%
1 Year Est. Return
+16%
3 Year Est. Return
+35.45%
5 Year Est. Return
+32.62%
10 Year Est. Return
+255.18%
AUM
$865M
AUM Growth
-$87.8M
Cap. Flow
-$74.5M
Cap. Flow %
-8.61%
Top 10 Hldgs %
17.44%
Holding
216
New
31
Increased
15
Reduced
74
Closed
16

Top Sells

Rank Stock Value
1
MJN
Mead Johnson Nutrition Company
MJN
+$12.1M
2
INTC icon
Intel
INTC
+$11.3M
3
NVDA icon
NVIDIA
NVDA
+$10.3M
4
B
Barrick Mining
B
+$9.14M
5
RHI icon
Robert Half
RHI
+$9.08M

Sector Composition

Rank Sector Weight
1 Technology 19.41%
2 Healthcare 18.32%
3 Consumer Discretionary 13.88%
4 Financials 7.96%
5 Materials 7.95%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PEP icon
26
PepsiCo
PEP
$196B
$9.48M 1.1%
101,600
-73,400
-42% -$7.01M
EXC icon
27
Exelon
EXC
$48.1B
$9.43M 1.09%
420,600
-70,100
-14% -$1.68M
SPLS
28
DELISTED
Staples Inc
SPLS
$9.32M 1.08%
609,000
+209,000
+52% +$3.4M
ZUMZ icon
29
Zumiez
ZUMZ
$330M
$9.32M 1.08%
350,000
DTV
30
DELISTED
DIRECTV COM STK (DE)
DTV
$9.28M 1.07%
100,000
IPXL
31
DELISTED
Impax Laboratories, Inc.
IPXL
$9.18M 1.06%
200,000
-50,000
-20% -$2.37M
OVTI
32
DELISTED
OMNIVISION TECHNOLOGIES INC
OVTI
$9.17M 1.06%
350,000
UNH icon
33
UnitedHealth
UNH
$382B
$9.15M 1.06%
75,000
-25,000
-25% -$2.96M
BRCD
34
DELISTED
Brocade Communications Systems, Inc. NEW
BRCD
$8.91M 1.03%
750,000
+100,000
+15% +$1.21M
WIP icon
35
State Street SPDR FTSE International Government Inflation-Protected Bond ETF
WIP
$467M
$8.79M 1.02%
160,000
GILD icon
36
Gilead Sciences
GILD
$165B
$8.78M 1.01%
+75,000
New +$8.2M
PNRA
37
DELISTED
Panera Bread Co
PNRA
$8.74M 1.01%
50,000
+25,000
+100% +$4.49M
CHE icon
38
Chemed
CHE
$7.16B
$8.52M 0.98%
65,000
-14,000
-18% -$1.73M
BP icon
39
BP
BP
$112B
$8.47M 0.98%
251,961
-145,760
-37% -$5.1M
WBA
40
DELISTED
Walgreens Boots Alliance
WBA
$8.44M 0.98%
100,000
WFC icon
41
Wells Fargo
WFC
$254B
$8.44M 0.97%
150,000
-50,000
-25% -$2.79M
V icon
42
Visa
V
$677B
$8.39M 0.97%
125,000
+25,000
+25% +$1.69M
BRLI
43
DELISTED
BIO-REFERENCE LABS INC-NEW-
BRLI
$8.37M 0.97%
203,000
ELV icon
44
Elevance Health
ELV
$81.5B
$8.21M 0.95%
50,000
TGT icon
45
Target
TGT
$66.3B
$8.16M 0.94%
+100,000
New +$8.09M
FDS icon
46
Factset
FDS
$10B
$8.13M 0.94%
50,000
STT icon
47
State Street
STT
$48.4B
$7.7M 0.89%
+100,000
New +$7.79M
IDCC icon
48
InterDigital
IDCC
$6.75B
$7.68M 0.89%
135,000
ISRG icon
49
Intuitive Surgical
ISRG
$127B
$7.27M 0.84%
135,000
+45,000
+50% +$2.52M
BDX icon
50
Becton Dickinson
BDX
$46.4B
$7.08M 0.82%
51,250

Similar funds

Hussman Strategic Advisors's Q2 2015 Portfolio in Review

As of Q2 2015, Hussman Strategic Advisors held 216 positions worth $865M, down 9.2% from $953M the previous quarter. Its ten largest holdings account for 17% of the portfolio.

Hussman Strategic Advisors withdrew a net $74.5M in Q2 2015, closing 16 positions and reducing 74 holdings. Its most notable exit was NVIDIA, an estimated $10.3M position sold in full.

By sector, the portfolio is most concentrated in Technology at 19% of assets, down from 20% a quarter earlier, followed by Healthcare and Consumer Discretionary.

Against the trend, Hussman Strategic Advisors opened a new position in Gilead Sciences worth $8.78M.

  • Hussman Strategic Advisors's largest Q2 2015 buy was Gilead Sciences: 75,000 shares worth $8.78M.
  • Hussman Strategic Advisors added most to American Eagle Outfitters in Q2 2015, an estimated $5.03M increase.
  • Hussman Strategic Advisors's biggest Q2 2015 reduction was Mead Johnson Nutrition Company, cutting an estimated $12.1M.
  • Hussman Strategic Advisors fully exited NVIDIA in Q2 2015, selling an estimated $10.3M.
  • Hussman Strategic Advisors's ten largest holdings make up 17% of its $865M portfolio in Q2 2015.
  • Hussman Strategic Advisors opened 31 new positions and closed 16 in Q2 2015.
  • Hussman Strategic Advisors's portfolio value fell 9.2% quarter-over-quarter to $865M.

Based on Hussman Strategic Advisors's 13F filing for Q2 2015, filed 31 Jul 2015.